gastrointestinal bleeding

(redirected from GI bleeding)

gastrointestinal bleeding

Any hemorrhage into the GI tract lumen, from esophagus–eg, from ruptured esophageal varices, to anus–eg from hemorrhoids
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

gastrointestinal bleeding

Bleeding from anywhere in the gastrointestinal tract.
Synonym: gastrointestinal hemorrhage
See also: bleeding
Medical Dictionary, © 2009 Farlex and Partners
References in periodicals archive ?
The diagnosis is triggered by GI bleeding, incidental findings during surgery or imaging and, in rare cases, tumour rupture or GI obstruction.
The researchers tallied rates of all-cause death, ischemic stroke, intracranial hemorrhage, hospitalization for GI bleeding, hospitalization for major bleeding, and the composite of these outcomes at follow-up.
Negligence of prescribing PPIs for patients in the high-risk group for NSAIDs-related GI bleeding is on one hand, whereas the inappropriate use of PPIs is on the other (1-4).
"If an individual has any abrasions in the GI tract or unbeknown to him has a peptic ulcer, taking a paracetamol without any pain, can irritate the lining of the stomach and aggravate an ulcer resulting in GI bleeding.
Data Extraction: Study characteristics including year of publication, the first author, country, study design, sample size, type of endoscopic treatment, mean age, concomitant diseases, and location of GI bleeding were extracted from eligible studies.
The recently published International Consensus Recommendations on the management of patients with non-variceal upper GI bleeding recommend "early risk stratification", by using validated prognostic scales.
In a 30-patient pilot trial, Mesoblast's allogenic mesenchymal precursor cell (MPC) therapy Revascor showed a 70 percent reduction in GI bleeding events.
Under the RMAT designation, Mesoblast received specific guidance from the FDA that reduction in major GI bleeding episodes and related hospitalizations in the current trial is a clinically meaningful outcome with a high unmet need that could meet requirements for an approvable regulatory endpoint.
Various malignancies with metastasis to the small intestine present as GI bleeding, which includes GI stromal tumor, intestinal lymphangiomas, Kaposi's sarcoma, melanoma, and breast cancer.
Aortoenteric fistula (AEF) is one of the rare causes of GI bleeding that can be fatal if not diagnosed and treated promptly.
The most conservative comparison yielded an NNH of 72 over 10 years of therapy (1.39 excess major GI bleeding events per 1000 person-years, 95% Cl, 0.70-2.28).